Lexaria Bioscience Corp. (LEXX)

Lexaria Bioscience Balance Sheet

Financials in millions USD. Fiscal year is September - August.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 30, 2025	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Cash & Equivalents	4.28	1.8	6.5	1.35	5.81	10.92
Short-Term Investments	0.14	0.17	0.06	0.13	0.35	0.83
Cash & Short-Term Investments	4.42	1.97	6.56	1.48	6.16	11.75
Cash Growth	-45.50%	-69.99%	343.63%	-76.01%	-47.58%	794.97%
Accounts Receivable	-	0.17	0.08	0.02	0.12	0.02
Other Receivables	0.09	0.19	0.07	0.1	0.08	0.33
Receivables	0.09	0.37	0.15	0.13	0.2	0.34
Inventory	-	-	-	-	0.04	0.03
Prepaid Expenses	0.85	1.13	1.19	0.55	0.58	0.32
Total Current Assets	5.36	3.47	7.9	2.15	6.98	12.44
Property, Plant & Equipment	0.32	0.33	0.39	0.42	0.37	0.46
Other Intangible Assets	0.31	0.31	0.52	0.46	0.49	0.36
Other Long-Term Assets	0.06	0.06	0.06	0.05	-	-
Total Assets	6.05	4.18	8.87	3.08	7.83	13.27
Accounts Payable	1.18	0.57	0.38	0.23	0.12	0.06
Accrued Expenses	0.25	0.89	0.69	0.01	0.03	0.05
Short-Term Debt	-	-	-	-	-	0.01
Current Portion of Leases	0.03	0.03	0.03	0.03	0.04	0.04
Current Income Taxes Payable	-	-	-	-	-	0
Current Unearned Revenue	-	-	0	-	-	-
Total Current Liabilities	1.46	1.49	1.1	0.27	0.19	0.15
Long-Term Leases	0.07	0.08	0.11	0.14	0.01	0.05
Total Liabilities	1.53	1.57	1.21	0.4	0.2	0.2
Common Stock	0.02	0.02	0.02	0.01	0.01	0.01
Additional Paid-In Capital	70.02	66.5	59.6	48.8	47.04	45.09
Retained Earnings	-65.06	-63.46	-51.56	-45.76	-39.1	-31.83
Comprehensive Income & Other	-0.08	-0.07	-0.02	-	-	-
Total Common Equity	4.91	2.99	8.04	3.04	7.95	13.27
Minority Interest	-0.39	-0.39	-0.38	-0.36	-0.32	-0.2
Shareholders' Equity	4.52	2.6	7.66	2.68	7.63	13.06
Total Liabilities & Equity	6.05	4.18	8.87	3.08	7.83	13.27
Total Debt	0.1	0.11	0.14	0.16	0.05	0.1
Net Cash (Debt)	4.32	1.86	6.42	1.31	6.11	11.65
Net Cash Growth	-45.88%	-71.05%	388.54%	-78.50%	-47.57%	907.32%
Net Cash Per Share	0.23	0.10	0.52	0.20	1.04	2.65
Filing Date Shares Outstanding	24.89	22.23	17.45	10.28	5.95	5.73
Total Common Shares Outstanding	22.23	19.56	15.81	8.09	5.95	5.73
Working Capital	3.91	1.97	6.8	1.88	6.78	12.29
Book Value Per Share	0.22	0.15	0.51	0.38	1.34	2.32
Tangible Book Value	4.6	2.68	7.52	2.58	7.46	12.9
Tangible Book Value Per Share	0.21	0.14	0.48	0.32	1.25	2.25
Machinery	0.54	0.54	0.51	0.47	0.44	0.39
Leasehold Improvements	0.26	0.26	0.26	0.26	0.26	0.26

Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q